Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Treatment for hepatitis B virus (HBV) and hepatitis C virus (HCV) infection - Danish national guidelines 2011

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Quality of diabetes treatment in four orthopaedic departments in the Capital Region of Denmark

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Lyme arthritis is rare in Eastern Denmark

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Heterogenicity in hospital service for children and adolescents with functional somatic symptoms

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. A major outbreak of covid-19 at a residential care home

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Reduction in maternal mortality in Denmark over three decades

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. The experience of pregnancy among women living with HIV in Nordic countries: A qualitative narrative enquiry

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Hepatitis B virus elimination status and strategies in circumpolar countries, 2020

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Neutralisation titres against SARS-CoV-2 are sustained 6 months after onset of symptoms in individuals with mild COVID-19

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations
The Danish Society of Infectious Diseases and Danish Society of Gastroenterology and Hepatology set up a committee in 2007 to produce national guidelines for treatment of viral hepatitis B and C. The 2011 version of the guidelines have been endorsed by the scientific societies and are presented below. Annual updates will be available at the websites of the societies. As this present English version has been written six months after the Danish 2011 version, it contains minor changes that will be integrated in the Danish 2012 version, available at the end this year. Epidemiology: Viral hepatitis is not common in Denmark. The prevalence has not been determined by national surveys, but it is estimated that 10,000-15,000 patients are chronically infected with hepatitis B and 15,000-20,000 with chronic hepatitis C. The majority of patients with HBV infection in Denmark are emigrants from high endemic countries, probably infected at birth or early childhood in their country of origin, while the majority of patients with HCV infection have been infected by drug use. For both groups it is estimated that only half of the patients have been diagnosed, of whom only 20% attends specialized care for their chronic viral hepatitis. Clinical care: According to the Danish National Board of Health, patients with chronic viral hepatitis should be followed with regular intervals, at clinics specialized in either infectious diseases or gastroenterology/hepatology. The primary aim is to identify patients with significant liver disease to initiate treatment in order to prevent development of cirrhosis and death. This is primarily done by liver biopsy, but screening for fibrosis with non-invasive methods such as elastography may be sufficient in some patients. Patients with established cirrhosis should enter screening programs for complications such as esophageal varices and hepatocellular carcinoma.
Original languageEnglish
JournalDanish Medical Journal
Volume59
Issue number6
Pages (from-to)C4465
Publication statusPublished - 2012

ID: 34903246